TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that it has applied for a primary listing on the Nasdaq OMX Stockholm Exchange in recognition of the Company’s large Swedish shareholding base and the historical trading volume of the Company’s common stock on the Exchange. Presently, the Company maintains a secondary listing on the Exchange, the status of which is dependent on the Company’s continued listing on a recognized national securities exchange in the United States. A decision on its application is expected within the next several months.
